1-2 of 2
Ana Romero
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Measurement of Serum N-Glycans in the Assessment of Early Vascular Aging (Arterial Stiffness) in Adults With Type 1 Diabetes

Gemma Llauradó, Núria Amigó, Rocío Fuertes-Martín, Ana Romero, Albert Cano, Lara Albert, Olga Giménez-Palop, Eugenio Berlanga, Sonia Fernández-Veledo, Xavier Correig, Joan Vendrell, José-Miguel González-Clemente
Journal: Diabetes Care
Diabetes Care 2022;45(10):2430–2438
https://doi.org/10.2337/dc22-0331
Published: 19 August 2022
View articletitled, Measurement of Serum N-Glycans in the Assessment of Early Vascular Aging (Arterial Stiffness) in Adults With Type 1 Diabetes
Open the PDF for Measurement of Serum N-Glycans in the Assessment of Early Vascular Aging (Arterial Stiffness) in Adults With Type 1 Diabetes in another window
Journal Articles

Comment on Fahrmann et al. Modification of the Association Between Severe Hypoglycemia and Ischemic Heart Disease by Surrogates of Vascular Damage Severity in Type 1 Diabetes During ∼30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care 2021;44;2132–2139

José-Miguel González-Clemente, Gemma Llauradó, Ana Romero, Olga Giménez-Palop, Eugenio Berlanga, Joan Vendrell
Journal: Diabetes Care
Diabetes Care 2022;45(3):e63–e64
https://doi.org/10.2337/dc21-2262
Published: 04 March 2022
View articletitled, Comment on Fahrmann et al. Modification of the Association Between Severe Hypoglycemia and Ischemic Heart Disease by Surrogates of Vascular Damage Severity in Type 1 Diabetes During ∼30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care 2021;44;2132–2139
Open the PDF for Comment on Fahrmann et al. Modification of the Association Between Severe Hypoglycemia and Ischemic Heart Disease by Surrogates of Vascular Damage Severity in Type 1 Diabetes During ∼30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care 2021;44;2132–2139 in another window